AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimismart MF 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Genuwin Lifesciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimismart MF 1mg/500mg Tablet SR

DiabetaComb 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This medication helps regulate blood glucose. DiabetaComb should be taken with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels and increased risk of complications like kidney impairment, vision loss, neuropathy, and limb amputation. Remember, it's a component of a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize its symptoms—sweating, lightheadedness, headache, tremors—and how to manage them. Regular meals and readily available fast-acting glucose sources (e.g., sugary foods, fruit juice) are vital. Alcohol consumption should be limited due to increased hypoglycemia risk. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for those with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before starting treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glimismart MF 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimismart MF 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimismart MF 1mg/500mg Extended-Release Tablets should be administered with a meal.

Common Side effects of Glimismart MF 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimismart MF 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimismart MF 1mg/500mg Tablet SR. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.

How Glimismart MF 1mg/500mg Tablet SR works:

Glimismart MF 1mg/500mg Extended-Release Tablets combine glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimismart MF 1mg/500mg Tablet SR with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glimismart MF 1mg/500mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

Extended-release Glimismart MF 1mg/500mg tablets are contraindicated during lactation due to the potential for infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Individuals with kidney impairment should use Glimismart MF 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Medical consultation is essential. This medication is contraindicated for patients experiencing severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

For individuals with liver impairment, Glimismart MF 1mg/500mg Tablet SR requires careful administration. Dosage modification of Glimismart MF 1mg/500mg Tablet SR may be necessary. Medical advice is recommended. In patients exhibiting mild to moderate liver disease, Glimismart MF 1mg/500mg Tablet SR is typically initiated at a reduced dosage; however, its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimismart MF 1mg/500mg Tablet SR :

Should you forget a dose of Glimismart MF 1mg/500mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimismart MF 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimismart MF 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimismart MF 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimismart MF 1mg/500mg Tablet SR and seek immediate medical attention.
Glimismart MF 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glimismart MF 1mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimismart MF 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Glimismart MF 1mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimismart MF 1mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimismart MF 1mg/500mg T...
66
MRP 81
18% off